Treatment of Young Children with HIV Infection: Using Evidence to Inform Policymakers

1. World Health Organization, UNAIDS 2011 Global HIV/AIDS response: progress report 2011. Available: http://www.unaids.org/en/resources/publications/2011/. Accessed 18 March 2012

2. NewellMLCoovadiaHCortina-BorjaMRollinsNGaillardP 2004 Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364 1236 1243

3. CoovadiaAAbramsEJStehlauRMeyersTMartensL 2010 Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA 304 1082 1090

4. KuhnLCoovadiaAStrehlauRMartensLHuCC 2012 Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis Epub ahead of print 15 March 2012

5. PalumboPLindseyJCHughesMDCottonMFBobatR 2010 Antiretroviral treatment for children with peripartum nevirapine exposure. N Eng J Med 363 1510 1520

6. PalumboPViolariALindseyJHughesMJean-PhilippeP 2011 NVP- vs LPV/r-based ART among HIV+ infants in resource-limited settings: the IMPAACT P1060 Trial. 18th Conference on Retroviruses and Opportunistic Infections; Boston, MA

7. PrendergastAMphatsweWTudor-WilliamsGRakgothoMPillayV 2008 Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS 22 1333 1343

8. ViolariACottonMFGibbDMBabikerAGSteynJ 2008 Early antiretroviral therapy and mortality among HIV-infected infants. N Eng J Med 359 2233 2244

9. PenazzatoMPrendergastATierneyJCottonMGibbDM 2012 Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Cochrane Database Syst Rev In press

10. BerkDRFalkovitz-HalpernMSHillDWAlbinCArrietaA 2005 Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA 293 2221 2231

11. FayeALe ChenadecJDollfusCThuretIDouardD 2004 Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis 39 1692 1698

12. LuzuriagaKMcManusMMofensonLBrittoPGrahamB 2004 A trial of three antiretroviral regimens in HIV-1-infected children. N Eng J Med 350 2471 2480

13. World Health Organization 2010 Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach Geneva WHO Available: http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html. Accessed 24 March 2012

14. BarkerPMMphatsweWRollinsN 2011 Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 56 e45 e48

15. CottonMViolariAGibbDOtwombeKJosipovicD Early ART followed by interruption is safe and is associated with better outcomes than deferred ART in HIV+ infants: final results from the 6-year randomized CHER trial, South Africa. 19th Conference on Retroviruses and Opportunistic Infections; 5–8 March 2012; Seattle, USA

16. Meyer-RathGViolariACottonMNdibongoBBrennanA 2010 The cost of early vs. deferred paediatric antiretroviral treatment in South Africa - a comparative economic analysis of the first year of the CHER trial. XVIII International AIDS Conference; Vienna, Austria

17. LockmanSShapiroRLSmeatonLMWesterCThiorI 2007 Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Eng J Med 356 135 147

18. BabikerACastro nee GreenHCompagnucciAFiscusSGiaquintoC 2011 First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis 11 273 283

19. JuddA The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord 2011 Early antiretroviral therapy in HIV-1 infected infants in Europe, 1996–2008: treatment response and duration of first line regimens. AIDS 25 2279 2287

20. BestBMCapparelliEVDiepHRossiSSFarrellMJ 2011 Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. J Acquir Immune Defic Syndr 58 385 391

21. McArthurMAKaluSUFoulksARAlyAMJainSK 2009 Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy. Pediatr Infect Dis J 28 1127 1129

22. SimonAWarszawskiJKariyawasamDLe ChenadecJBenhammouV 2011 Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers. JAMA 306 70 78

23. MulengaVCookAWalkerASKabambaDChijokaC 2010 Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination “baby pills” in Zambia: a randomized controlled trial. Clin Infect Dis 51 1081 1089

24. LockmanSHughesMDMcIntyreJZhengYChipatoT 2010 Antiretroviral therapies in women after single-dose nevirapine exposure. N Eng J Med 363 1499 1509

25. CiaranelloALLockmanSFreedbergKAHughesMChuJ 2011 First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS 25 479 492

26. UNAIDS 2011 Countdown To Zero: global plan towards elimination of new HIV infections among children by 2015 and keeping their mothers alive Geneva UNAIDS Available: http://www.unaids.org/en/. Accessed 16 March 2012

27. UNAIDS 2011 The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. Available: http://data.unaids.org/pub/Outlook/2010/20100713_outlook_treatment2_0_en.pdf. Accessed on 24 March 2012

28. LallemantMChangSCohenRPecoulB 2011 Pediatric HIV–a neglected disease? N Eng J Med 365 581 583

29. WamalwaDBenki-NugentSLangatATapiaKNgugiE 2012 Treatment interruption in infants following 24 months of empiric ART: Kenya. 19th Conference on Retroviruses and Opportunistic Infections; 5–8 March 2012; Seattle, USA